As a senior patent agent, Cara Mosley applies her background in medicinal chemistry and more than 15 years of legal experience to cultivate and manage patent rights for clients innovating in the chemical arts.
Cara strategically develops and prosecutes patent portfolios for formulations (including pharmaceuticals, transdermal devices, foods and beverages, and cosmetics), small molecule therapeutics, radiopharmaceuticals, cyclic peptides, lipid nanoparticles, and polymeric products.
For expected drug products, Cara devises bespoke patent portfolios to maximize product exclusivity, considering drug development and approval timelines, regulatory exclusivity, and the competitive landscape.
Cara prepares and prosecutes patent applications in the U.S. Patent and Trademark Office (USPTO) and in international patent offices. In her work with the USPTO, Cara utilizes expedited examination programs, appeals, and various pilot programs. Cara has also assisted with adversarial proceedings in a variety of foreign patent offices.
Cara conducts due diligences of patent estates for licensing, acquisitions, investments, and royalty purchases. She also assists with preparation of legal opinions, e.g., patentability, freedom-to-operate, and validity opinions.
Cara holds a Ph.D. in chemistry from Emory University, where her thesis focused on the design, synthesis, and biological activity of N-methyl-D-aspartate (NMDA) receptor antagonists for treatment of neurological diseases. During her time at Emory, she also interned in the Office of Technology Transfer.
